2024 ICD-10-CM Diagnosis Code Z85.850

Approximate Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

• H/O: thyroid disorder
• H/O: thyroid disorder
• H/O: thyroid disorder
• H/O: thyroid disorder
• History of follicular adenocarcinoma of thyroid
• History of malignant neoplasm of endocrine gland
• History of malignant neoplasm of endocrine gland
• History of malignant neoplasm of endocrine gland
• History of malignant neoplasm of endocrine gland
• History of malignant neoplasm of neck
• History of malignant neoplasm of neck
• History of malignant neoplasm of neck
• History of malignant neoplasm of neck
• History of malignant neoplasm of thyroid
• History of medullary carcinoma of thyroid
• History of papillary adenocarcinoma of thyroid

Code Edits

The Medicare Code Editor (MCE) detects and reports errors in the coding of claims data. The following ICD-10-CM Code Edits are applicable to this code:

• Unacceptable principal diagnosis - There are selected codes that describe a circumstance which influences an individual's health status but not a current illness or injury, or codes that are not specific manifestations but may be due to an underlying cause. These codes are considered unacceptable as a principal diagnosis.

Z85.850 is grouped with Diagnostic Related Groups - MS-DRG Mapping

Diagnostic Related Groups (DRGs) are a classification system used to group together diagnosis codes for the purpose of reimbursement and healthcare management. DRGs are used to standardize the way hospitals and other providers are paid for inpatient services. In this system patients are grouped together based on their principal diagnosis in areas referred to as Major Diagnostic Categories (MDC). Once a patient is assigned a particular diagnostic category, providers receive a predetermined payment rate for the services rendered. This reimbursement rate is often fixed and is meant to cover the cost of care for that patient. Reimbursement is also affected by the relative weight of a diagnostic related group based on the severity of a patient's illness and the associated cost of care during hospitalization.

Diagnostic related groups encourage healthcare providers to focus on quality and efficiency in patient care while managing costs effectively. The diagnosis code is present in the following groups for version MS-DRG V41.0 applicable from 10/01/2023 through 09/30/2024.

MS-DRG	MS-DRG Title	MCD	Relative Weight
826	MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITH MCC	17	4.3888
827	MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITH CC	17	2.3172
828	MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITHOUT CC/MCC	17	1.6404

The relative weight of a diagnostic related group determines the reimbursement rate based on the severity of a patient's illness and the associated cost of care during hospitalization.

Present on Admission (POA)

Z85.850 is exempt from POA reporting - The Present on Admission (POA) indicator is used for diagnosis codes included in claims involving inpatient admissions to general acute care hospitals. POA indicators must be reported to CMS on each claim to facilitate the grouping of diagnoses codes into the proper Diagnostic Related Groups (DRG). CMS publishes a listing of specific diagnosis codes that are exempt from the POA reporting requirement. Review other POA exempt codes here.

CMS POA Indicator Options and Definitions

POA Indicator	Reason for Code	CMS will pay the CC/MCC DRG?
Y	Diagnosis was present at time of inpatient admission.	YES
N	Diagnosis was not present at time of inpatient admission.	NO
U	Documentation insufficient to determine if the condition was present at the time of inpatient admission.	NO
W	Clinically undetermined - unable to clinically determine whether the condition was present at the time of inpatient admission.	YES
1	Unreported/Not used - Exempt from POA reporting.	NO

Convert Z85.850 to ICD-9-CM

• ICD-9-CM Code: V10.87 - Hx of thyroid malignancy

Patient Education

Thyroid Cancer

What is thyroid cancer?

Thyroid cancer is a cancer that starts in the tissues of the thyroid. Your thyroid is a small, butterfly-shaped gland in the front of your neck. It makes hormones that control the way the body uses energy. These hormones affect nearly every organ in your body and control many of your body's most important functions. For example, they affect your breathing, heart rate, weight, digestion, and moods.

What are the different types of thyroid cancer?

There are different types of thyroid cancer; the main ones include:

• Differentiated thyroid cancer, which includes papillary cancer and follicular cancer
• Medullary thyroid cancer
• Anaplastic thyroid cancer

Who is more likely to develop thyroid cancer?

Certain people are more likely to develop thyroid cancer. Your risk is higher if you:

• Are between ages 25 and 65
• Are a woman
• Are Asian
• Were exposed to certain types of radiation, including from radiation treatments to your head or neck as a child or from a radiation emergency
• Have had a goiter (enlarged thyroid)
• Having certain genetic conditions, including certain types of multiple endocrine neoplasia
• Have a family history of thyroid cancer or thyroid disease

What are the symptoms of thyroid cancer?

Thyroid cancer may not cause symptoms at first. It is sometimes found during a routine physical exam. You may get signs or symptoms as the cancer gets bigger. The symptoms may include:

• A lump (nodule) in the neck
• Trouble breathing
• Trouble swallowing
• Pain when swallowing
• Hoarseness or other changes to your voice that do not get better

How is thyroid cancer diagnosed?

To find out if you have thyroid cancer, your health care provider may use:

• A physical exam, including checking your neck for swelling, lumps, or anything that seems unusual
• A medical history
• Thyroid tests
• Other blood or imaging tests
• A biopsy

What are the treatments for thyroid cancer?

Treatment for thyroid cancer depends on the type of cancer you have and whether the cancer has spread. Often, more than one type of treatment may be needed. The treatment options include:

• Surgery.
• Radiation therapy, including radioactive iodine therapy.
• Chemotherapy.
• Thyroid hormone therapy.
• Targeted therapy, which uses drugs or other substances that attack specific cancer cells with less harm to normal cells.
• Watchful waiting, which means that you don't get treatment right away. Your regularly checks to see if your signs or symptoms appear or change.

NIH: National Cancer Institute

[Learn More in MedlinePlus]

Thyroid Cancer—Patient Version

Learn about thyroid cancer risk factors, symptoms, tests to diagnose, factors affecting prognosis, staging, and treatment.
[Learn More in MedlinePlus]

Code History

• FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
• FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
• FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
• FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
• FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
• FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
• FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
• FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
• FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.